Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
2.720
+1.315 (93.59%)
At close: Jan 30, 2026, 4:00 PM EST
2.750
+0.030 (1.10%)
After-hours: Jan 30, 2026, 7:38 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $13.4 million as of January 30, 2026. Its market cap has decreased by -65.61% in one year.
Market Cap
13.40M
Enterprise Value
14.29M
1-Year Change
-65.61%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $13.40M, a decrease of -84.88%. That is a compound annual growth rate of -33.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 13.40M | -5.23% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 15.04M |
| CalciMedica | 14.70M |
| Applied Therapeutics | 14.56M |
| Hoth Therapeutics | 14.20M |
| Kairos Pharma | 13.84M |
| Cocrystal Pharma | 13.78M |
| Cellectar Biosciences | 13.74M |
| BioLineRx | 13.52M |